Antibody responses following vaccination in lupus patients [2]

Revista de Investigacion Clinica

Volumn 55, Issue 1, 2003, Pages 93-94

  Mercádo, Ulises ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BACTERIAL ANTIGEN; CARRIER PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS VACCINE; PREDNISONE; PULMOVAX; TETANUS TOXOID;

ADOLESCENT; ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; ENZYME IMMUNOASSAY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; LETTER; NONHUMAN; SIDE EFFECT; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION;

ANTIBODIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; VACCINES;

EID: 18144444159     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Klippel JH, Karsh J, Stahl NI, et al. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1321-5.
2. Lipnick RN, Karsh J, Stahl NI, et al. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 1985; 12: 1118-21.
3. Battafarano, DF, Battafarano NJ, Larsen L, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998; 41: 1828-34.
4. Guzman J, Cardiel MH, Arce-Salinas A, et al. Measure of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992; 19: 1551-8.